Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation

The European Journal of Neuroscience
Michio MiyoshiTatsuo Watanabe

Abstract

We investigated whether angiotensin (ANG) II and its receptors contribute to lipopolysaccharide (LPS)-induced microglial activation through activation of the proinflammatory transcription factors nuclear factor kappaB (NF-kappaB) and activator protein-1 (AP-1). Using primary microglial cell cultures, we examined whether losartan [ANG type 1 receptor (AT(1)) antagonist] alters the effects of LPS on: the production of interleukin-1 (IL-1) and nitric oxide, cell morphology, and NF-kappaB and AP-1 activities. Reverse transcription-polymerase chain reaction revealed that LPS-stimulated microglial cells exhibited marked mRNA expression for AT(1), ANG type 2 receptor (AT(2)) and the ANG II precursor angiotensinogen, whereas non-stimulated microglial cells expressed only those for AT(2) and angiotensinogen. We further demonstrated marked peptide/protein expression for AT(1) and ANG II in LPS-activated microglial cells. LPS (100 ng/mL)-stimulated microglial cells showed increased concentrations of IL-1 and nitrite (a relatively stable metabolite of nitric oxide), and increased expression of IL-1 mRNA as well as a morphological change from an amoeboid shape to a multipolar (mostly bipolar but sometimes tripolar) rod shape. These effects ...Continue Reading

References

Sep 1, 1992·Brain Research. Brain Research Reviews·J W Wright, J W Harding
May 1, 1992·Neuroendocrinology·B P RoweR C Speth
Apr 20, 1999·Biochemical and Biophysical Research Communications·R KranzhöferW Kübler
Oct 31, 2002·The European Journal of Neuroscience·Carme SolàJoan Serratosa
Mar 11, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Michio MiyoshiTatsuo Watanabe
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Yusuke SuzukiJesus Egido
Jun 12, 2003·Blood Pressure·Elena Kaschina, Thomas Unger
Nov 24, 2004·Metabolic Brain Disease·Denise van Rossum, Uwe-Karsten Hanisch
Dec 14, 2004·International Immunopharmacology·Xiu Li BiChun Fu Wu
Dec 17, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nikolay M FilipovDavid A Lawrence
Apr 9, 2005·Journal of Inflammation·Gary Robert Smith, Sotiris Missailidis
Jun 4, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H TakatsunaK Umezawa
Aug 12, 2005·Journal of Neurochemistry·Josep SauraJoan Serratosa
Nov 26, 2005·Journal of Biomedical Science·Rolis Chien-Wei HouKee-Ching G Jeng
Apr 8, 2006·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Rainer Schulz, Gerd Heusch
May 16, 2006·Experimental Eye Research·Iliyana IlievaShigeaki Ohno
Jun 24, 2006·Seminars in Fetal & Neonatal Medicine·Xiaoyang WangCarina Mallard
Oct 28, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cheng-Yun JinGi-Young Kim

❮ Previous
Next ❯

Citations

Mar 5, 2009·Cellular and Molecular Neurobiology·Julius BenickyJuan M Saavedra
Dec 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Julius BenickyJuan M Saavedra
Apr 23, 2013·Clinical and Experimental Pharmacology & Physiology·Claudia A McCarthyJennifer L Wilkinson-Berka
Apr 27, 2012·International Journal of Inflammation·Toshihide KuriharaKazuo Tsubota
Feb 25, 2017·Brain, Behavior, and Immunity·Antonio Dominguez-MeijideJose L Labandeira-Garcia
Aug 17, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Adnan I Qureshi, Mushtaq H Qureshi
Apr 16, 2016·Circulation Research·Monica M SantistebanMohan K Raizada
May 18, 2016·PloS One·Nofar TorikaSigal Fleisher-Berkovich
Apr 30, 2011·Physiological Reviews·Helmut KettenmannAlexei Verkhratsky
Aug 6, 2014·Current Hypertension Reports·Aline M HilzendegerMichael J Katovich
Jun 19, 2015·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Annette D de KloetColin Sumners
Dec 8, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Vinicia Campana BiancardiJavier E Stern
Jan 27, 2015·Current Hypertension Reports·Douglas M BennionColin Sumners
May 19, 2017·Frontiers in Aging Neuroscience·Jose L Labandeira-GarciaMaria J Guerra
Jun 3, 2010·The Journal of Pharmacology and Experimental Therapeutics·Karen NahmodThomas Walther
Jul 30, 2011·Journal of Neurochemistry·E L O'CallaghanA M Allen
Dec 23, 2019·Cellular and Molecular Neurobiology·Rohan Umesh ParekhSrinivas Sriramula
Dec 17, 2018·Molecular Neurobiology·Daniel YoungerNamas Chandra
Jul 11, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ana I Rodriguez-PerezJose L Labandeira-Garcia
Oct 9, 2015·Journal of Neurochemistry·Meng LiuColin Sumners
Sep 22, 2020·Pharmacology & Therapeutics·Jason D Vadhan, Robert C Speth
Dec 22, 2019·Brain, Behavior, and Immunity·Ana I Rodriguez-PerezJose L Labandeira-Garcia
Nov 13, 2020·Frontiers in Neurology·Jianhua XiongJianning Zhang
Nov 25, 2017·Translational Research : the Journal of Laboratory and Clinical Medicine·Sailesh C Harwani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.